Endocytic relay as a potential means for enhancing ligand transport through cellular tissue matrices: Analysis and possible implications for drug delivery

Tissue Engineering

Volumn 2, Issue 1, 1996, Pages 17-38

  Chu, Lily ^a   Steven Wiley, H ^b   Lauffenburger, Douglas A ^c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Massachusetts Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL TRANSPORT; DRUG TRANSPORT; ENDOSOME; EXTRACELLULAR MATRIX; MATHEMATICAL MODEL; MEMBRANE TRANSPORT; PRIORITY JOURNAL;

EID: 8944256875     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.1996.2.17     Document Type: Article

References (95)

1. Mendelsohn, J. Growth factor receptors as targets for antitumor therapy with monoclonal antibodies. In Waldmann, H., ed., Monoclonal Antibody Therapy. New York: Karger, 1988, p. 147.
2. Trowbridge, I.S. Transferrin receptor as a potential therapeutic target. In Waldmann, H., ed., Monoclonal Antibody Therapy. New York: Karger, 1988, p. 121.
3. Modjtahedi, H., and Dean, C. The receptor for EGF and its ligands - expression, prognostic value and target for therapy in cancer (Review). Int. J. Oncol. 4, 277, 1994.
4. Poznansky, M.J., and Juliano, R.L. Biological approaches to the controlled delivery of drugs: A critical review. Pharmacol. Rev. 36, 277, 1984.
5. Basu, S.K. Receptor-mediated endocytosis of macromolecular conjugates in selective drug delivery. Biochem. Pharmacol. 40, 1941, 1990.
6. Wagner, E., Curiel, D., and Cotten, M. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis. Adv. Drug Delivery Rev. 14, 113, 1994.
7. Findeis, M.A., Merwin, J.R., Spitalny, G.L., and Chiou, H.C. Targeted delivery of DNA for gene therapy via receptors. Trends Biotechnol. 11, 202, 1993.
8. Michael, S.I., and Curiel, D.T. Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. Gene Ther. 1, 223, 1994.
9. Pardridge, W.M., Eisenberg, J., and Yang, J. Human blood-brain barrier transferrin receptor. Metabolism 36, 892, 1987.
10. Pardridge, W.M., Buciak, J.L., and Friden, P.M. Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. J. Pharmacol. Exp. Ther. 259, 66, 1991.
11. Duffy, K.R., and Pardridge, W.M. Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res. 420, 32, 1987.
12. Pardridge, W.M. Peptide drug delivery to the brain. New York: Raven Press, 1991, p. 357.
13. Bickel, U., Yoshikawa, T., Landaw, E.M., Faull, K.F., and Pardridge, W.M. Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc. Natl. Acad. Sci. U.S.A. 90, 2618, 1993.
14. Friden, P.M., Walus, L.R., Watson, P., Doctrow, S.R., Kozarich, J.W., Bäckman, C., Bergman, H., Hoffer, B., Bloom, F., and Granholm, A.-C. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259, 373, 1993.
15. Bickel, U., Kang, Y.-S., and Pardridge, W.M. In vivo cleavability of a disulfide-based chimeric opioid peptide in rat brain. Bioconjug. Chem. 6, 211, 1995.
16. King, G.L., and Johnson, S.M. Receptor-mediated transport of insulin across endothelial cells. Science 227, 1583, 1985.
17. Maratos-Flier, E., Kao, C.-Y.Y., Verdin, E.M., and King, G.L. Receptor-mediated vectorial transcytosis of epidermal growth factor by Madin-Darby canine kidney cells. J. Cell Biol. 105, 1595, 1987.
18. Ghinea, N., Hai, M.T.V., Groyer-Picard, M.-T., and Milgrom, E. How protein hormones reach their target cells. Receptor-mediated transcytosis of hCG through endothelial cells. J. Cell Biol. 125, 87, 1994.
19. Akiyama, S.-I., Gottesman, M.M., Hanover, J.A., Fitzgerald, D.J.P., Willingham, M.C., and Pastan, I. Verapamil enhances the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin and antitransferrin receptor with Pseudomonas exotoxin. J. Cell. Physiol. 120, 271, 1984.
20. O'Keefe, D.O., and Draper, R.K. Characterization of a transferrin-diphtheria toxin conjugate. J. Biol. Chem. 260, 932, 1985.
21. Theuer, C.P., FitzGerald, D., and Pastan, I. A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing. J. Biol. Chem. 267, 16872, 1992.
22. Leamon, C.P., and Low, P.S. Selective targeting of malignant cells with cytotoxin-folate conjugates. J. Drug Targeting 2, 101, 1994.
23. Till, M.A., Ghetie, V., Gregory, T., Patzer, E.J., Porter, J.P., Uhr, J.W., Capon, D.J., and Vitetta, E.S. HIV-infected cells are killed by rCD4-ricin A chain. Science 242, 1166, 1988.
24. Heimbrook, D.C., Stirdivant, S.M., Ahern, J.D., Balishin, N.L., Patrick, D.R., Edwards, G.M., Defeo-Jones, D., FitzGerald, D.J., Pastan, I., and Oliff, A. Transforming growth factor α-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts. Proc. Natl. Acad. Sci. U.S.A. 87, 4697, 1990.
25. Hirota, N., Ueda, M., Ozawa, S., Abe, O., and Shimizu, N. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody. Cancer Res. 49, 7106, 1989.
26. Pai, L.H., Batra, J.K., FitzGerald, D.J., Willingham, M.C., and Pastan, I. Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin. Proc. Natl. Acad. Sci. U.S.A. 88, 3358, 1991.
27. Barel, A., Jori, G., Perm, A., Romandini, P., Pagnan, A., and Biffanti, S. Role of high-, low, and very low-density lipoproteins in the transport and tumor-delivery of hematoporphyrin in vivo. Cancer Lett. 32, 145, 1986.
28. Langer, R. New methods of drug delivery. Science 249, 1527, 1990.
29. Saltzman, W.M. Rational design of delivery methods for drugs and vaccines. Bioeng. Sci. News 18, 15, 1994.
30. Petersen, M.J., Kaplan, J., Jorgensen, C.M., Schmidt, L.A., Li, L., Morgan, J.R., Kwan, M.K., and Krueger, G.G. Sustained production of human transferrin by transduced fibroblasts implanted into athymic mice: A model for somatic gene therapy. J. Invest. Dermatol. 104, 171, 1995.
31. Sung, C., Shockley, T.R., Morrison, P.F., Dvorak, H.F., Yarmush, M.L., and Dedrick, R.L. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors. Cancer Res. 52, 377, 1992.
32. Aubrée-Lecat, A., Duban, M.C., Demignot, S., Domurado, M., Fournié, P., and Domurado, D. Influence of barrier-crossing limitations on the amount of macromolecular drug taken up by its target. J. Pharmacokinet. Biopharm. 21, 75, 1993.
33. Saltzman, W.M., and Radomsky, M.L. Drugs released from polymers: Diffusion and elimination in brain tissue. Chem. Eng. Sci. 46, 2429, 1991.
34. Rippley, R., and Stokes, C.L. Effects of cellular pharmacology on drug distribution in tissues. Biophys. J. 69, 825, 1995.
35. Mayo, K.H., Nunez, M., Burke, C., Starbuck, C., Lauffenburger, D., and Savage, C.R. Epidermal growth factor receptor binding is not a simple one-step process. J. Biol. Chem. 264, 17838, 1989.
36. Lund, K.A., Opresko, L.K., Starbuck, C., Walsh, B.J., and Wiley, H.S. Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization. J. Biol. Chem. 265, 15713, 1990.
37. Wiley, H.S., Herbst, J.J., Walsh, B.J., Lauffenburger, D.A., Rosenfeld, M.G., and Gill, G.N. The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J. Biol. Chem. 266, 11083, 1991.
38. Sorkin, A., and Waters, C.M. Endocytosis of growth factor receptors. Bioessays 15, 375, 1993.
39. French, A.R., Sudlow, G.P., Wiley, H.S., and Lauffenburger, D.A. Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions. J. Biol. Chem. 269, 15749, 1994.
40. Herbst, J.J., Opresko, L.K., Walsh, B.J., Lauffenburger, D.A., and Wiley, H.S. Regulation of postendocytic trafficking of the epidermal growth factor receptor through endosomal retention. J. Biol. Chem. 269, 12865, 1994.
41. Gill, G.N., Bertics, P.J., and Santon, J.B. Epidermal growth factor and its receptor. Mol. Cell. Endocrinol. 51, 169, 1987.
42. Carpenter, G., and Wahl, M.I. The epidermal growth factor family. In Sporn, M.B., and Roberts, A.B., eds., Peptide Growth Factors and their Receptors. New York: Springer-Verlag, 1990, p. 69.
43. Aaronson, S.A. Growth factors and cancer. Science 254, 1146, 1991.
44. Jain, R.K. Delivery of novel therapeutic agents in tumors: Physiological barriers and strategies. J. Natl. Cancer Inst. 81, 570, 1989.
45. Shockley, T.R., Lin, K., Nagy, J.A., Tompkins, R.G., Dvorak, H.F., and Yarmush, M.L. Penetration of tumor tissue by antibodies and other immunoproteins. Ann. N.Y. Acad. Sci. 618, 367, 1991.
46. Bond, J.S., and Beynon, R.J. Proteolysis and physiological regulation. Mol. Aspects Med. 9, 173, 1987.
47. Young, P.K., and Grinnell, F. Metalloproteinase activation cascade after burn injury: A longitudinal analyis of the human wound environment. J. Invest. Dermatol. 103, 660, 1994.
48. Ray, J.M., and Stetler-Stevenson, W.G. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Respir. J. 7, 2062, 1994.
49. Kasahara, N., Dozy, A.M., and Kan, Y.W. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266, 1373, 1994.
50. Rojanasakul, Y., Wang, L.Y., Malanga, C.J., Ma, J.K.H., and Liaw, J. Targeted gene delivery to alveolar macrophages via Fc receptor-mediated endocytosis. Pharm. Res. 11, 1731, 1994.
51. Wu, G.Y., Zhan, P., Sze, L.L., Rosenberg, A.R., and Wu, C.H. Incorporation of adenovirus into a ligand-based DNA carrier system results in retention of original receptor specificity and enhances targeted gene expression. J. Biol. Chem. 269, 11542, 1994.
52. Zwiebel, J.A., Freeman, S.M., Newman, K., Dichek, D., Ryan, U.S., and anderson, W.F. Drug delivery by genetically engineered cell implants. Ann. N.Y. Acad. Sci. 618, 394, 1991.
53. Krueger, G.G., Morgan, J.R., Jorgensen, C.M., Schmidt, L., Li, H.L., Kwan, M.K., Boyce, S.T., Wiley, H.S., Kaplan, J., and Petersen, M.J. Genetically modified skin to treat disease: Potential and limitations. J. Invest. Dermatol. 103, 76s, 1994.
54. Will, B.H., Lauffenburger, D.A., and Wiley, H.S. Studies on engineered autocrine systems: Requirements for ligand release from cells producing an artificial growth factor. Tissue Eng. 1, 81, 1995.
55. Schreier, H., Moran, P., and Caras, I.W. Targeting of liposomes to cells expressing CD4 using glycosylphos-phatidylinositol-anchored gp120 - Influence of liposome composition on intracellular trafficking. J. Biol. Chem. 269, 9090, 1994.
56. van't Hof, R.J., Defize, L.H.K., Nuijdens, R., de Brabander, M., Verkleij, A.J., and Boonstra, J. Dynamics of epidermal growth factor receptor internalization studied by nanovid light microscopy and electron microscopy in combination with immunogold labeling. Eur. J. Cell Biol. 48, 5, 1989.
57. Thatte, H.S., Bridges, K.R., and Golan, D.E. Microtubule inhibitors differentially affect translational movement, cell surface expression, and endocytosis of transferrin receptors in K562 Cells. J. Cell. Physiol. 160, 345, 1994.
58. Sorkin, A., Kornilova, E., Teslenko, L., Sorokin, A., and Nikolsky, N. Recycling of epidermal growth factor-receptor complexes in A431 cells. Biochim. Biophys. Acta 1011, 88, 1989.
59. Dautry-Varsat, A., Ciechanover, A., and Lodish, H.F. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc. Natl. Acad. Sci. U.S.A. 80, 2258, 1983.
60. Klausner, R.D., Ashwell, G., van Renswoude, J., Harford, J.B., and Bridges, K.R. Binding of apotransferrin to K562 cells: Explanation of the transferrin cycle. Proc. Natl. Acad. Sci. U.S.A. 80, 2263, 1983.
61. Koval, M., and Pagano, R.E. Sorting of an internalized plasma membrane lipid between recycling and degradative pathways in normal and niemann-pick, Type A fibroblasts. J. Cell Biol. 111, 429, 1990.
62. Mayor, S., Presley, J.F., and Maxfield, F.R. Sorting of membrane components from endosomes and subsequent recycling to the cell surface occurs by a bulk flow process. J. Cell Biol. 121, 1257, 1993.
63. Ascher, U., and Bader, G. ftp site: netlib@ornl.gov COLNEW. 1987.
64. Chu, L. Peptide growth factor transport via endocytic relay: Mathematical model and analysis. M.S. thesis, University of Illinois at Urbana-Champaign, 1995.
65. Swabb, E.A., Wei, J., and Gullino, P.M. Diffusion and convection in normal and neoplastic tissues. Cancer Res. 34, 2814, 1974.
66. Beaty, C.E., and Saltzman, W.M. Controlled growth factor delivery induces differential neurite outgrowth in three-dimensional cell cultures. J. Controlled Release 24, 15, 1993.
67. Papini, D., Stella, V.J., and Topp, E.M. Diffusion of macromolecules in membranes of hyaluronic acid esters. J. Controlled Release 27, 47, 1993.
68. Lee, V.H.L. Enzymatic barriers to peptide and protein absorption. Crit. Rev. Ther. Drug Carrier Syst. 5, 69, 1988.
69. Buckley, A., Davidson, J.M., Kamerath, C.D., Wolt, T.B., and Woodward, S.C. Sustained release of epidermal growth factor accelerates wound repair. Proc. Natl. Acad. Sci. U.S.A. 82, 7340, 1985.
70. Davidson, J.M., Klagsbrun, M., Hill, K.E., Buckley, A., Sullivan, R., Brewer, P.S., and Woodward, S.C. Accelerated wound repair, cell proliferation, and collagen accumulation are produced by a cartilage-derived growth factor. J. Cell Biol. 100, 1219, 1985.
71. Schultz, G., Khaw, P.T., Oxford, K., Macauley, S., van Setten, G., and Chegini, N. Growth factors and ocular wound healing. Eye 8, 184, 1994.
72. Murakami, T., Misake, M., Kojima, Y., Yamada, M., Yuki, M., Higashi, Y., Amagase, H., Fuwa, T., and Yata, N. Effect of absorption promoters on subcutaneous absorption of human epidermal growth factor in rats. J. Pharm. Sci. 82, 236, 1993.
73. Hopkins, C.R., and Trowbridge, I.S. Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells. J. Cell Biol. 97, 508, 1983.
74. Cain, C.C., Wilson, R.B., and Murphy, R.F. Isolation by fluorescence-activated cell sorting of Chinese hamster ovary cell lines with pleiotropic temperature-conditional defects in receptor recycling. J. Biol. Chem. 266, 11746, 1991.
75. Johnson, L.S., Dunn, K.W., Pytowski, B., and McGraw, T.E. Endosome acidification and receptor trafficking-bafilomycin A(1) slows receptor externalization by a mechanism involving the receptor's internalization motif. Mol. Biol. Cell 4, 1251, 1993.
76. Ghosh, R.N., Gelman, D.L., and Maxfield, F.R. Quantification of low density lipoprotein and transferrin endocytic sorting in HEp2 cells using confocal microscopy. J. Cell Sci. 107, 2177, 1994.
77. Young, S.P., and Bomford, A. Iterative endocytosis of transferrin by K562 cells. Biochem. J. 298, 165, 1994.
78. Starbuck, C. Quantitative studies of epidermal growth factor receptor binding and intracellular trafficking dynamics in fibroblasts: Relationship to cell proliferation. Ph.D. Thesis, University of Pennsylvania, 1991.
79. Starbuck, C., Wiley, H.S., and Lauffenburger, D.A. Epidermal growth factor binding and trafficking dynamics in fibroblasts: Relationship to cell proliferation. Chem. Eng. Sci. 45, 2367, 1990.
80. Starbuck, C., and Lauffenburger, D.A. Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses. Biotech. Prog. 8, 132, 1992.
81. Riley, M.R., Muzzio, F.J., Buettner, H.M., and Reyes, S.C. Diffusion in heterogeneous media: Applications to immobilized cell systems. AIChE J. 41, 691, 1995.
82. Hay, E.D. Cell biology of extracellular matrix. New York: Plenum Press, 1991, p. 468.
83. Gallagher, J.T., Lyon, M., and Steward, W.P. Structure and function of heparan sulphate proteoglycans. Biochem. J. 236, 313, 1986.
84. Comper, W.D. Extracellular matrix interactions: Sulfation of connective tissue polysaccharides creates macroion binding templates and conditions for dissipative structure formation. J. Theor. Biol. 145, 497, 1990.
85. Burgess, W.H., and Maciag, T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58, 575, 1989.
86. Ruoslahti, E., and Yamaguchi, Y. Proteoglycans as modulators of growth factor activities. Cell 64, 867, 1991.
87. Nugent, L.J., and Jain, R.K. Extravascular diffusion in normal and neoplastic tissues. Cancer Res. 44, 238, 1984.
88. Gerlowski, L.E., and Jain, R.K. Microvascular permeability of normal and neoplastic tissues. Microvasc. Res. 31, 288, 1986.
89. Laiho, M., and Keski-Oja, J. Growth factors in the regulation of pericellular proteolysis: A review. Cancer Res. 49, 2533, 1989.
90. Sommer, A., and Rifkin, D.B. Interaction of heparin with human basic fibroblast growth factor: Protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan. J. Cell. Physiol. 138, 215, 1989.
91. van den Heuvel, M., Nusse, R., Johnston, P., and Lawrence, P.A. Distribution of the wingless gene product in drosophila embryos: A protein involved in cell-cell communication. Cell 59, 739 1989.
92. Gonzalez, F., Swales, L., Bejsovec, A., Skaer, H., and Arias, A.M. Secretion and movement of wingless protein in the epidermis of the Drosophila embryo. Mech. Dev. 35, 43, 1991.
93. Bejsovec, A., and Wieschaus, E. Signaling activities of the Drosophila wingless gene are separately mutable and appear to be transduced at the cell surface. Genetics 139, 309, 1995.
94. French, A.R. Quantitative characterization of endosomal sorting of epidermal growth factor/receptor complexes. M.S. thesis, University of Illinois at Urbana-Champaign, 1993.
95. Lauffenburger, D.A., and Linderman, J.J. Receptors: Models for binding, trafficking, and signaling. New York: Oxford University Press, 1993, p. 365.